Mitochondria at the Crossroads of Survival and DemiseView this Special Issue
Research Article | Open Access
Loren P. Thompson, Hong Song, Brian M. Polster, "Fetal Programming and Sexual Dimorphism of Mitochondrial Protein Expression and Activity of Hearts of Prenatally Hypoxic Guinea Pig Offspring", Oxidative Medicine and Cellular Longevity, vol. 2019, Article ID 7210249, 11 pages, 2019. https://doi.org/10.1155/2019/7210249
Fetal Programming and Sexual Dimorphism of Mitochondrial Protein Expression and Activity of Hearts of Prenatally Hypoxic Guinea Pig Offspring
Chronic intrauterine hypoxia is a programming stimulus of cardiovascular dysfunction. While the fetal heart adapts to the reduced oxygenation, the offspring heart becomes vulnerable to subsequent metabolic challenges as an adult. Cardiac mitochondria are key organelles responsible for an efficient energy supply but are subject to damage under hypoxic conditions. We propose that intrauterine hypoxia alters mitochondrial function as an underlying programming mechanism of contractile dysfunction in the offspring. Indices of mitochondrial function such as mitochondrial DNA content, Complex (C) I-V expression, and CI/CIV enzyme activity were measured in hearts of male and female offspring at 90 days old exposed to prenatal hypoxia (10.5% O2) for 14 d prior to term (65 d). Both left ventricular tissue and cardiomyocytes exhibited decreased mitochondrial DNA content, expression of CIV, and CI/CIV activity in male hearts. In female cardiomyocytes, hypoxia had no effect on protein expression of CI-CV nor on CI/CIV activity. This study suggests that chronic intrauterine hypoxia alters the intrinsic properties of select respiratory complexes as a programming mechanism of cardiac dysfunction in the offspring. Sex differences in mitochondrial function may underlie the increased vulnerability of age-matched males compared to females in cardiovascular disease and heart failure.
In adult hearts, the mitochondria play an important role in contractile function in generating 90% of ATP via oxidative phosphorylation [1, 2]. Since the heart has a relatively low ATP content and a high energy demand , the generation and delivery of the energy supply to the myofibrils must be highly efficient. In contrast to the adult, the early fetal heart relies predominantly on glycolysis for its energy supply because (1) glucose is a major energy substrate, (2) the glycolytic enzymes are upregulated via hypoxia signaling , and (3) oxidative phosphorylation is inefficient, resulting from a less organized ultrastructure within the mitochondria and in association with the myofibrils [4, 5]. However, despite the reliance on glycolysis as a metabolic pathway, oxidative capacity of the fetal heart is still important as the heart undergoes a metabolic switch to oxidative phosphorylation in preparation to and following birth [3, 6–11]. Thus, intrauterine stressors that alter the normal fetal heart growth pattern and cellular organization may alter the maturational progress of fetal cardiac metabolism by disrupting both myofibrillar development and mitochondrial function.
The adult heart relies predominantly on the TCA cycle and β-oxidation to provide NADH and FADH2 to the electron transport chain for oxidative phosphorylation. Under normal conditions, electrons are transported from CI to CIV, where O2 is reduced to H2O, and a H+ gradient is generated by CI, CIII, and CIV, which is the driving force for ATP synthase activity . The efficiency of ATP generation is dependent on the efficiency of electron flux along the respiratory chain and O2 reduction by cytochrome c oxidase within the inner mitochondrial membrane. Altered expression of mitochondrial protein and altered respiratory complex activity can result in reduced electron flux, excess electron accumulation, and generation of superoxide anions from CI, CIII, and TCA cycle dehydrogenase enzymes sensitive to the NADH/NAD+ ratio [12, 13]. These events lead to reduced ATP synthesis . In both animal and human studies, altered cardiac mitochondrial protein expression and activity are associated with heart dysfunction and failure, contributing to cardiovascular disease [14–19].
Now, decades of research have established the negative impact of intrauterine stress on fetal growth and development and its lasting consequences of increased risk of adult cardiovascular disease [20, 21]. Early epidemiological studies have provided insight into cardiovascular programming, showing that intrauterine growth restriction of the fetus increases the risk of hypertension, coronary artery disease, and heart dysfunction [17, 20–25]. Animal models of gestational hypoxia [26–28] have been generated to investigate the underlying mechanisms of cardiovascular programming of the offspring. Intrauterine hypoxia is one of the most important obstetric complications that reduce fetal growth, which increases the risk of cardiovascular disease in the adult [20–25]. Animal models have shown that gestational hypoxia increases the risk of ischemia/reperfusion injury of adult rat hearts [26, 29–33], hypertension and cardiac dysfunction  and altered cardiomyocyte endowment of adult guinea pigs , and altered systemic vascular resistance in adult rats . Thus, the impact of intrauterine stress such as prenatal hypoxia increases the vulnerability of the offspring to a lifetime of cardiovascular disease [20, 21].
Mitochondria are highly susceptible to hypoxia, which leads to respiratory chain dysfunction [36, 37]. We previously reported a decrease in cardiac CIV mRNA/protein expression and CIV activity of left ventricles along with a decrease in oxygen consumption rates of freshly isolated cardiac cells from hearts of male offspring guinea pigs following exposure to prenatal hypoxia . This study demonstrated that prenatal hypoxia decreases cardiac performance of adult offspring guinea pigs, which was also accompanied by decreased cardiac CIV activity and respiratory function .
The goal of the current study was to more fully characterize the programming effects of prenatal hypoxia on cardiac mitochondria of adult guinea pig hearts in an animal model that exhibits sex-related differences in contractile dysfunction in the adult offspring . Mitochondrial indices such as mitochondrial DNA content, CI-V protein expression, and CI and CIV activity were measured in both the left ventricle of the heart and in cardiomyocytes isolated from hearts of male and female adult guinea pigs. We propose that mitochondrial programming of cardiomyocytes of fetal hearts is initiated in utero by prenatal hypoxia as an underlying cause of mitochondrial and contractile dysfunction in the adult.
All animal procedures were approved by the University of Maryland Institutional Animal Care and Use Committee in accordance with the Association for Assessment and Accreditation of Laboratory Animal Care—accredited procedures (Animal Welfare Assurance No. A3200-01).
2.1. Animal Model
Pregnant guinea pigs were generated by mating multiple females with one male following the presence of an open vaginal membrane. Females were kept with males for a maximum of 48 hours or until the presence of vaginal membrane closure. Gestational age was estimated by palpation  and then confirmed at the time of delivery. Pregnant guinea pigs were exposed to either normoxia (room air, 21% O2) for the entire gestation or hypoxia (HPX, 10.5% O2, duration of 14 d) at 50 d gestation until delivery (). Pups were vaginally delivered and removed from the HPX chamber upon birth, and both male and female offspring were raised in a NMX environment. Animals were weighed at birth and weaned at 30 d old, and body weight and food and water intake rates were measured in 3 d intervals until 90 d old, when tissues were obtained. To remove the heart, guinea pig offspring were anesthetized with ketamine (80 mg/kg, s.c.) and xylazine (10 mg/kg, s.c.), and a thoracotomy was performed following an abdominal skin injection of lidocaine (1%). Hearts were excised and weighed and either dissected into left and right ventricles and frozen in liquid N2 or mounted onto a perfusion apparatus for collection of cardiomyocytes.
2.2. Cardiomyocyte Isolation
To obtain cardiac cells, hearts were excised from male and female offspring, immediately placed in iced physiological buffer solution (PBS), and mounted via the aorta onto a glass cannula of a Langendorff heart perfusion apparatus . Using a modified procedure for isolating fetal sheep cardiac cells , hearts were retrograde-perfused at 37°C with a low Ca2+ (no Ca2+ added) Tyrode’s solution (composition (in mM): 140 NaCl, 5 KCl, 10 HEPES, 10 glucose, and 1 MgCl2, pH 7.35) without enzymes for 5 minutes, followed by Tyrode’s solution containing enzymes (collagenase (80 U/ml), protease (0.59 U/ml), and albumin (1 mg/ml)) for 12 min. This was followed by perfusion with Kraft-Bruhe (KB) buffer (composition (mM): 30 KCl, 10 HEPES, 10 glucose, 74 potassium glutamate, 20 taurine, 1.5 MgSO4·7H2O, 0.5 EGTA, and 30 KH2PO4, pH 7.37) for 5 minutes to wash out the enzymes. Hearts were removed from the apparatus and placed in a beaker containing warmed KB buffer for gentle mincing to release cells from the heart. Cells were filtered through a 150 μm nylon mesh and transferred to a 15 ml centrifuge tube. Cells then were washed two times with KB buffer by centrifugation (200-250 g, 10 minutes), resuspended in 5 ml DMEM (Life Technologies, #12320-032), and pelleted by centrifugation at 1,200 g for 10 minutes. The final cell pellet was frozen in liquid N2 until assayed.
2.3. Mitochondrial Isolation
Mitochondrial proteins of left ventricular heart tissue and of cardiomyocytes were obtained from separate groups of 90 d old prenatally NMX or HPX guinea pigs. For assays of CI-V Western immunoblotting and CI and CIV activity assays, the mitochondrial fraction was isolated using a standard differential centrifugation protocol [41, 42]. Briefly, the frozen heart tissues (20-30 mg) were ground to a fine powder in liquid N2, and the frozen cardiomyocytes from separate animals were washed with 9 volumes of ice-cold PBS. Both were then separately resuspended in 1 ml of ice-cold Homogenization Buffer (0.25 M sucrose, 5 mM HEPES, and 1 mM EDTA, pH 7.2) and homogenized for 10 minutes at 4°C. Samples were centrifuged twice at 600 g for 10 minutes at 4°C to remove cellular debris. The supernatant was recentrifuged at 12,500 g for 10 min to generate an enriched mitochondrial fraction. The pellet containing the mitochondrial fraction was resuspended in 1x RIPA Lysis buffer supplemented with a protease inhibitor (Bio-Rad, Hercules, CA) for Western Blot or was solubilized with 0.1 mM N-Dodecyl β-D-maltoside (Sigma-Aldrich, St. Louis, MO) for complex activity assays. Total protein concentration of each sample was determined by the Bio-Rad Protein Assay (Bio-Rad).
2.4. Quantitative Real-Time PCR (qRT-PCR) of Mitochondrial DNA
Mitochondrial DNA (mtDNA) content was measured as an index of mitochondrial density. Total genomic DNA was isolated using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions from left ventricular heart tissue prenatally exposed to NMX or HPX of 90 d old guinea pigs. DNA concentration was determined by NanoDrop (Thermo Fisher Scientific, Waltham, MA). Relative quantification of mtDNA content for each group was determined by qRT-PCR using primers for a mitochondrial gene (mt-ND1, forward 5 - CTAAAAACCCTTGCGCTCAC -3 ; reverse 5 -TGGGAAGGGAAATGTGTCAT -3 ) and a nuclear gene (β-actin, forward 5 -ACTCTCCACCTTCCAGCAGA -3 ; reverse 5 -AAAGCCATGCCAATCTCATC-3 ). qPCR was performed with a two-step cycling program by using the SYBR Green ROX™ qPCR Mastermix (Qiagen) and read on the QuantStudio 3 Real-time PCR System (Thermo Fisher). Gene expression was quantified by using the 2-ΔΔCt method .
2.5. Blue Native Gel Electrophoresis and Western Blot Analysis
2.5.1. Blue Native Gel Electrophoresis
Blue Native one-dimensional electrophoresis was performed for identification of whole respiratory complexes in isolated mitochondrial fractions of left ventricles of NMX and HPX offspring hearts. Isolated mitochondrial membrane fractions were isolated as previously described. The pellet was solubilized with 0.1 mM N-Dodecyl β-D-maltoside (Sigma-Aldrich, St. Louis, MO) similar to that for activity assays. To separate the respiratory chain complexes, 30 μg of mitochondrial protein was loaded onto a high-resolution Clear Native PAGE of 3-12% Bis-Tris gradient gel (Thermo Fisher Scientific). The gel was stained with Coomassie dye and destained according to standard methods. The bands of individual complexes were visualized by the ChemiDoc Touch Imaging System (Bio-Rad).
2.5.2. Western Blot Analysis
Protein expression of mitochondrial respiratory Complexes I-V was measured by Western immunoblot. Mitochondrial protein fractions obtained from left ventricular heart tissues and cardiomyocytes from separate groups of prenatally NMX and HPX 90 d old offspring were run on separate gels. Mitochondrial proteins (4 μg) were separated on 4-15% precast gradient gels (Bio-Rad) and then transferred to PVDF membranes. The membranes were blocked with 5% nonfat milk in TBST for 2 hrs, incubated overnight at 4°C with primary antibody diluted in 5% nonfat milk in TBST, and then detected using an appropriate peroxidase-conjugated secondary antibody. Protein bands were targeted with an antibody cocktail (1 : 500) containing antibodies for complex subunits (I: NDUFB8, 20 kDa MW; II: SDHB, 30 kDa MW; III: UQCRC2 48 kDa MW; IV: MITCO1, 40 kDa MW; and V: ATP5a, 55 kDa MW) (Abcam, Cambridge, MA) and polyclonal anti-VDAC (voltage-dependent anion channel) antibody (1 : 2,000, Boster Biological Technology Co., Pleasanton, CA) and visualized by the ChemiDoc Touch Imaging System (Bio-Rad). Band densities were quantified by the Bio-Rad Image Lab System and normalized to the loading control, VDAC, to confirm equal loading.
2.6. Complex I and IV Activity Assays
Complex I and IV enzyme activity rates were measured using mitochondrial protein fractions of left ventricular heart tissue and cardiomyocytes isolated from hearts of separate groups of 90 d old prenatally NMX or HPX guinea pigs. Complex I enzyme activity was measured as the oxidation of NADH to NAD+ with a Complex I Enzyme Activity Microplate Assay Kit from Abcam (Cambridge, MA), an assay that measures the diaphorase-type activity of Complex I, which is independent of ubiquinone and rotenone sensitivity. Briefly, mitochondrial proteins were isolated as previously described, and 5 μg was added to the microplate wells precoated with Complex I-specific antibody. After 3 hrs of incubation at 25°C, substrate (NADH and dye) was added to the wells, and OD values measured at 450 nm were recorded. Enzyme activity was expressed as the change in OD values per minute per mg protein.
Complex IV (cytochrome c oxidase) activity is responsible for reduction of O2 to H2O and is a measure of the oxidative capacity of the respiratory chain . Cytochrome c oxidase activity was measured colorimetrically by monitoring the rate of oxidation of reduced cytochrome c (ferrocytochrome c). Briefly, the mitochondrial protein amount (2-4 μg) was optimized to generate a reaction rate that followed first order kinetics, which is related to chemical reactions that are dependent on the molar concentration of one reactant. Following optimization, mitochondrial proteins (3 μg) were added to a 96-well plate containing the assay buffer (10 mM Tri-HCl, pH 7.0, and 120 mM KCl plus 0.04 mM reduced cytochrome c (Sigma-Aldrich, St. Louis, MO) following reduction by 3 mM dithiothreitol. The OD values generated by oxidation of the reduced cytochrome c were measured as a decrease in absorbance at 550 nm in a 96-well plate reader (BioTek, Winooski, VT) at 10 sec intervals. Characteristics of first order kinetics were observed as cytochrome c oxidase activity was inhibited by generation of the ferricytochrome c product from oxidation of the ferrocytochrome c, and the reaction was slowed. The reaction rates of each sample were directly determined from a tangent drawn on the reaction curve at the 3 min time interval. Thus, the observed kinetics of the reaction reflects the complex interaction of the effect of decreasing substrate concentration and increasing product inhibition on cytochrome c oxidase . , ().
3.1. Animal Model
Neonates exposed to prenatal HPX exhibited a decrease in birth weight in both male ( values: 8 NMX, 8 HPX) and female ( values: 8 NMX, 8 HPX) offspring compared to age-matched NMX controls (Figure 1). At 90 d old, offspring body weights were no different between treatment groups for both sexes. There were no differences in food or water intake rates between NMX and prenatally HPX offspring as reported in a previous study . There were no morphological differences in total heart weight, left ventricular weight, heart weight/body weight ratios (Figure 1), or left ventricular weight/heart weight ratios (male: vs. ; female: vs. , NMX vs. HPX, respectively) between NMX and HPX animals. This is identical to the growth profile we previously reported , in which body weights of prenatally HPX offspring were reduced at birth and 30 days old but were similar at 60 and 90 days old. Sex differences in body weights were found at 90 days old, with males exhibiting greater weight than females.
3.2. Mitochondrial Content
Mitochondrial content was measured by qRT-PCR of mitochondrial DNA. Prenatal HPX significantly () reduced mtDNA (Figure 2) in left ventricular heart tissue of male offspring. There was a significant decrease in mito DNA content in female compared to male left ventricles although prenatal HPX had no effect on mtDNA content in female heart tissue.
3.3. Complex I-V Subunit Protein Expression
Figure 3 is a one-dimensional BN-PAGE gel illustrating the presence of fully assembled respiratory Complexes I-V extracted from mitochondrial fractions of left ventricular tissue homogenates. Each of the bands correspond to an individual intact respiratory complex and were confirmed by the MW. This indicates that all five complexes are fully assembled following extraction and exposure to hypoxia. The effect of HPX treatment on expression of individual complexes was investigated by performing Western blot analysis of individual subunits corresponding to Complexes I-V. Representative Western blots of Complex I-V subunit expression for left ventricles for NMX and HPX, male and female hearts, are illustrated in Figure 4. Figure 5 illustrates the graphic analysis of the effects of HPX on representative mitochondrial CI-V subunit expression in both left ventricular homogenates and freshly isolated cells of offspring hearts (NMX: 7 males, 7 females; HPX: 7 males, 7 females). In tissue homogenates, prenatal HPX significantly inhibited () the protein subunit expression of all 5 complexes in male offspring and subunits of CI, CIII, and CIV in female offspring (Figure 5). In cardiac cells derived from male hearts, prenatal HPX significantly inhibited () CIV subunit expression only. In cells from female hearts, prenatal HPX had no significant effect on expression of any of the 5 complexes.
3.4. Complex (C) I and IV Activity Rates
CI activity was significantly reduced in both left ventricular heart tissue (NMX: , 8 males, 8 females; HPX: , 8 males, 8 females) and cardiomyocytes (NMX: , 8 males, 8 females; HPX: , 8 males, 8 females) from male hearts of prenatally HPX offspring compared to their NMX controls (Figure 6). Similarly, CIV activity rates were reduced in both heart tissue and cardiomyocytes of male hearts of prenatally HPX offspring. In contrast, prenatal HPX had no effect on either CI or CIV activity in either female heart tissue or cardiomyocytes from female hearts.
This study presents evidence that prenatal HPX induces alterations in cardiac mitochondria that are manifested in offspring hearts as decreased mitochondrial content, decreased CIV expression, and decreased CI/CIV activity. Secondly, there is a sexual dimorphism in response of the mitochondria to prenatal HPX favoring female preservation of complex expression and activity compared to males. While prenatal HPX reduces body weight in both sexes at birth, following catch-up growth, there are no differences in body weight, heart weight, or relative heart weight at 90 days old. Despite this, there were significant changes in indices of cardiac mitochondrial function.
4.1. Programming of Cardiac Mitochondrial Function
Efficient delivery of ATP via oxidative phosphorylation is critical for maintaining normal heart function . The impact of prenatal HPX on cardiac mitochondria of offspring identifies a programming effect that may contribute to an underlying cause of heart dysfunction. The current study provides new information on indices of mitochondrial function that are altered by exposure to prenatal HPX and confirms our previous result . We have previously reported that prenatal HPX programs contractile dysfunction in male but not female offspring hearts in association with a decrease in CIV activity [34, 38] and oxygen consumption of cardiac cells .
A decrease in mitochondrial DNA content was measured in prenatally HPX males but not females. This may reflect an effect of prenatal HPX on mitophagy since HPX is an important regulator of mitochondrial degradation . Under conditions of chronic HPX, the fetal heart may regulate its mitochondrial content by removing defective mitochondria as a cardioprotective mechanism . It is unknown whether the sustained decrease in mitochondrial content of prenatally HPX offspring hearts is due to changes occurring in the fetal heart and sustained postnatally or occurring at the time of birth in response to the hyperoxic environment into which the fetus is born. Regardless, it suggests that prenatal HPX contributes to the sustained changes in the offspring.
Prenatal HPX decreased subunit expression of CI-CV in male and CI, CIII, and CIV in female heart tissue homogenates but only CIV in freshly isolated cardiomyocytes of male hearts. Cells were isolated from whole heart tissue to identify the cell-specific effects of prenatal HPX. It should be noted that the intact complex is made up of several subunits, whose numbers vary depending on the complex. Altered subunit expression may impact assembly of the respiratory complex and its functional activity . The small differences in subunit protein expression with HPX may indicate that the reduced protein expression is of small physiological significance. However, differences in transcriptional regulation of complex subunits may manifest in several other aspects of mitochondrial function such as CI/CIV activity measured in the current study and a decreased oxygen consumption rate of intact cells, as reported in our previous study . The difference of prenatal HPX on complex subunit expression between whole tissue and isolated cells may reflect the difference in heterogeneous versus homogeneous cell populations. In isolated cardiac cells, the decrease in CIV subunit expression is small but significant in males but not females, consistent with the sex differences in CIV activity. However, CI activity was reduced but in the absence of decreased CI subunit expression, suggesting posttranslational regulation of enzyme activity. The decrease in both CI and CIV activities may also reflect several aspects of mitochondrial function besides altering energy supply . For example, decreased CI activity can increase the premature leakage of electrons from the electron transport chain to generate superoxide anions, resulting in mitochondrial oxidative stress [37, 49–51]. Additionally, this may increase the NADH/NAD+ ratio due to decreased NADH consumption by CI, with the resulting increase in NADH inhibition to enzymes in the TCA cycle [52, 53]. Data from the current study corroborate our previous report that both the maximal oxygen consumption rate and respiratory reserve capacity were reduced in cells derived from prenatally HPX male but not female hearts . Thus, prenatal HPX may change the intrinsic properties of the respiratory complexes in the offspring heart and thereby decrease respiratory function.
4.2. Implications of Programming on Heart Function in the Offspring
The mechanism of programming of mitochondrial dysfunction in offspring hearts is poorly understood because of the maturational changes the fetal heart undergoes as well as the environmental changes to which the neonate is exposed. The mitochondria of the fetal heart undergo a maturational process that involves both structural organization and functional changes in preparation of the metabolic switch that occurs at birth [5, 54]. Intrauterine HPX can disrupt this process directly, by generating mitochondria-derived ROS [37, 49–51], or indirectly, by disrupting transcriptional regulation of mitochondrial proteins  and/or altering complex activity [55, 56]. It is unclear whether HPX conditions disrupt mitochondrial respiration via enhanced ROS generation, causing oxidative damage, or via altered electron flux as a result of reduced complex activity. Regardless, there is a close association between altered cardiac mitochondrial and contractile function in the hearts of offspring , which suggests a programming effect of prenatal HPX as an underlying mechanism.
4.3. Sex Differences in Mitochondrial Function
While mitochondrial sex differences in response to prenatal HPX were present, the mechanisms underlying these differences are unclear. Sex differences in response to prenatal HPX may have their origins in the fetus, offspring, or both. Sex differences of the fetus are associated with both the genetic makeup of the embryo/fetus [57, 58] and underlying differences in fetal hormone levels such as testosterone and estrogen [59–61]. Thus, differences in response to HPX in the offspring may originate from either the genetic background or the differences in fetal hormones, which may contribute to the differences in epigenetic mechanisms induced by HPX . Further, the placenta may contribute to the sexual dimorphism in its response to intrauterine stress  due to differences in hormone synthesis (i.e., cortisol and testosterone) . We have previously shown that HPX reduces CI and CIV activities in male versus female placentas under identical conditions as the current study . Thus, differences in placental hormones may contribute to the fetal response to intrauterine hypoxia and its subsequent effects in the offspring.
Differences in sex steroid hormones in the reproductively mature adult may also contribute to the sex differences in mitochondrial complex activity. The mitochondria are considered major targets of cardioprotective signaling by estrogen, whose levels differ between male and female. It is reasonable to consider that a secondary effect of postpubertal steroid levels in female offspring may protect against and even reverse the altered mitochondrial effects programmed by prenatal HPX. Several studies have demonstrated estrogen’s protective effects by enhancing the antioxidant capacity in female compared to male mitochondria [60, 61, 64, 65] as well as stimulating mitochondrial biogenesis by upregulating PGC-1β and NRF1 via nuclear gene transcription by binding to ERα/β (61).
In conclusion, mitochondrial dysfunction is a contributing factor to heart dysfunction and eventual heart failure as a result of inadequate energy delivery to the myofibrils . Sex differences in mitochondrial protein expression and activity in response to HPX may contribute to sex difference in heart failure  and cardiovascular disease  with age-matched men having a higher incidence than women. Extensive study has now identified multiple mechanisms by which intrauterine HPX can program heart dysfunction in the adult [27, 28, 68]. We propose that the cardiac mitochondria are critical downstream target organelles whose intrinsic properties of the respiratory chain complexes are altered by intrauterine HPX. Thus, the programming of the cardiac mitochondria by prenatal HPX may play a central role in cardiac dysfunction in the adult, given its importance in cell metabolism, energy supply, and contractile function. Further, the dysregulation of cardiac mitochondrial function, initiated in utero, may contribute to the vulnerability of the offspring to factors contributing to cardiovascular disease [66, 67] and heart failure [16, 66].
The data used to support the findings of this study are available from the corresponding author upon request.
The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.
Conflicts of Interest
No conflicts of interest, financial or otherwise, are declared by the authors.
All authors contributed equally to the conception and design of the experiments, interpretation of results, and writing and revising of the manuscript; HS generated the data. All authors approved the final version of the manuscript before submission.
The authors thank Gerard Pinkas for technical assistance in generating and maintaining the animal colony. This project is supported in part by the National Heart, Lung, and Blood Institute Grant HL-126859 (LPT).
- G. D. Lopaschuk, J. R. Ussher, C. D. L. Folmes, J. S. Jaswal, and W. C. Stanley, “Myocardial fatty acid metabolism in health and disease,” Physiological Reviews, vol. 90, no. 1, pp. 207–258, 2010.
- J. R. Neely, M. J. Rovetto, and J. F. Oram, “Myocardial utilization of carbohydrate and lipids,” Progress in Cardiovascular Diseases, vol. 15, no. 3, pp. 289–329, 1972.
- M. T. Neary, K. E. Ng, M. H. R. Ludtmann et al., “Hypoxia signaling controls postnatal changes in cardiac mitochondrial morphology and function,” Journal of Molecular and Cellular Cardiology, vol. 74, pp. 340–352, 2014.
- R. J. Ascuitto and N. T. Ross-Ascuitto, “Substrate metabolism in the developing heart,” Seminars in Perinatology, vol. 20, no. 6, pp. 542–563, 1996.
- A. Gonzalez-Tendero, I. Torre, P. Garcia-Canadilla et al., “Intrauterine growth restriction is associated with cardiac ultrastructural and gene expression changes related to the energetic metabolism in a rabbit model,” American Journal of Physiology–Heart and Circulatory Physiology, vol. 305, no. 12, pp. H1752–H1760, 2013.
- C. A. Sheldon, W. F. Friedman, and H. D. Sybers, “Scanning electron microscopy of fetal and neonatal lamb cardiac cells,” Journal of Molecular and Cellular Cardiology, vol. 8, no. 11, pp. 853-854, 1976.
- D. J. Fisher, M. A. Heymann, and A. M. Rudolph, “Myocardial oxygen and carbohydrate consumption in fetal lambs in utero and in adult sheep,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 238, no. 3, pp. H399–H405, 1980.
- G. Olivetti, P. Anversa, and A. V. Loud, “Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. II. Tissue composition, capillary growth, and sarcoplasmic alterations,” Circulation Research, vol. 46, no. 4, pp. 503–512, 1980.
- A. O. Makinde, P. F. Kantor, and G. D. Lopaschuk, “Maturation of fatty acid and carbohydrate metabolism in the newborn heart,” Molecular and Cellular Biochemistry, vol. 188, no. 1/2, pp. 49–56, 1998.
- G. D. Lopaschuk, M. A. Spafford, and D. R. Marsh, “Glycolysis is predominant source of myocardial ATP production immediately after birth,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 261, Part 2, no. 6, pp. H1698–H1705, 1991.
- J. Piquereau and R. Ventura-Clapier, “Maturation of cardiac energy metabolism during perinatal development,” Frontiers in Physiology, vol. 9, 2018.
- A. A. Starkov, G. Fiskum, C. Chinopoulos et al., “Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species,” The Journal of Neuroscience, vol. 24, no. 36, pp. 7779–7788, 2004.
- V. Adam-Vizi and L. Tretter, “The role of mitochondrial dehydrogenases in the generation of oxidative stress,” Neurochemistry International, vol. 62, no. 5, pp. 757–763, 2013.
- C. Mittmann, T. Eschenhagen, and H. Scholz, “Cellular and molecular aspects of contractile dysfunction in heart failure,” Cardiovascular Research, vol. 39, no. 2, pp. 267–275, 1998.
- J. Casademont and Ò. Miró, “Electron transport chain defects in heart failure,” Heart Failure Reviews, vol. 7, no. 2, pp. 131–139, 2002.
- J. Marin-Garcia and M. J. Goldenthal, “Mitochondrial centrality in heart failure,” Heart Failure Reviews, vol. 13, no. 2, pp. 137–150, 2008.
- A. M. Nuyt and B. T. Alexander, “Developmental programming and hypertension,” Current Opinion in Nephrology and Hypertension, vol. 18, no. 2, pp. 144–152, 2009.
- L. A. Kiyuna, R. P. e. Albuquerque, C.-H. Chen, D. Mochly-Rosen, and J. C. B. Ferreira, “Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities,” Free Radical Biology and Medicine, vol. 129, pp. 155–168, 2018.
- J. Wu, Z. Zeng, W. Zhang et al., “Emerging role of SIRT3 in mitochondrial dysfunction and cardiovascular diseases,” Free Radical Research, vol. 53, no. 2, pp. 139–149, 2019.
- D. J. P. Barker, K. M. Godfrey, P. D. Gluckman, J. E. Harding, J. A. Owens, and J. S. Robinson, “Fetal nutrition and cardiovascular disease in adult life,” The Lancet, vol. 341, no. 8850, pp. 938–941, 1993.
- P. D. Gluckman, M. A. Hanson, C. Cooper, and K. L. Thornburg, “Effect of in utero and early-life conditions on adult health and disease,” The New England Journal of Medicine, vol. 359, no. 1, pp. 61–73, 2008.
- D. J. P. Barker, C. Osmond, P. D. Winter, B. Margetts, and S. J. Simmonds, “Weight in infancy and death from ischaemic heart disease,” The Lancet, vol. 334, no. 8663, pp. 577–580, 1989.
- G. C. Curhan, W. C. Willett, E. B. Rimm, D. Spiegelman, A. L. Ascherio, and M. J. Stampfer, “Birth weight and adult hypertension, diabetes mellitus, and obesity in US men,” Circulation, vol. 94, no. 12, pp. 3246–3250, 1996.
- D. A. Leon, H. O. Lithell, D. Vagero et al., “Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915-29,” BMJ, vol. 317, no. 7153, pp. 241–245, 1998.
- J. H. Dasinger, G. K. Davis, A. D. Newsome, and B. T. Alexander, “Developmental programming of hypertension: physiological mechanisms,” Hypertension, vol. 68, no. 4, pp. 826–831, 2016.
- D. A. Giussani, E. J. Camm, Y. Niu et al., “Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress,” PLoS One, vol. 7, no. 2, article e31017, 2012.
- D. A. Giussani and S. T. Davidge, “Developmental programming of cardiovascular disease by prenatal hypoxia,” Journal of Developmental Origins of Health and Disease, vol. 4, no. 5, pp. 328–337, 2013.
- L. Zhang, “Prenatal hypoxia and cardiac programming,” Journal of the Society for Gynecologic Investigation, vol. 12, no. 1, pp. 2–13, 2005.
- G. Li, Y. Xiao, J. L. Estrella, C. A. Ducsay, R. D. Gilbert, and L. Zhang, “Effect of fetal hypoxia on heart susceptibility to ischemia and reperfusion injury in the adult rat,” Journal of the Society for Gynecologic Investigation, vol. 10, no. 5, pp. 265–274, 2003.
- G. Li, S. Bae, and L. Zhang, “Effect of prenatal hypoxia on heat stress-mediated cardioprotection in adult rat heart,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 286, no. 5, pp. H1712–H1719, 2004.
- Y. Xu, S. J. Williams, D. O’Brien, and S. T. Davidge, “Hypoxia or nutrient restriction during pregnancy in rats leads to progressive cardiac remodeling and impairs postischemic recovery in adult male offspring,” The FASEB Journal, vol. 20, no. 8, pp. 1251–1253, 2006.
- Q. Xue and L. Zhang, “Prenatal hypoxia causes a sex-dependent increase in heart susceptibility to ischemia and reperfusion injury in adult male offspring: role of protein kinase C epsilon,” The Journal of Pharmacology and Experimental Therapeutics, vol. 330, no. 2, pp. 624–632, 2009.
- C. F. Rueda-Clausen, J. S. Morton, G. D. Lopaschuk, and S. T. Davidge, “Long-term effects of intrauterine growth restriction on cardiac metabolism and susceptibility to ischaemia/reperfusion,” Cardiovascular Research, vol. 90, no. 2, pp. 285–294, 2011.
- L. P. Thompson, L. Chen, B. M. Polster, G. Pinkas, and H. Song, “Prenatal hypoxia impairs cardiac mitochondrial and ventricular function in guinea pig offspring in a sex-related manner,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 315, no. 6, pp. R1232–R1241, 2018.
- K. J. Botting, X. Y. Loke, S. Zhang, J. B. Andersen, J. R. Nyengaard, and J. L. Morrison, “IUGR decreases cardiomyocyte endowment and alters cardiac metabolism in a sex- and cause-of-IUGR-specific manner,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 315, no. 1, pp. R48–R67, 2018.
- L. C. Heather, M. A. Cole, J.-J. Tan et al., “Metabolic adaptation to chronic hypoxia in cardiac mitochondria,” Basic Research in Cardiology, vol. 107, no. 3, p. 268, 2012.
- S. H. Hassanpour, M. A. Dehghani, and S. Z. Karami, “Study of respiratory chain dysfunction in heart disease,” Journal of Cardiovascular and Thoracic Research, vol. 10, no. 1, pp. 1–13, 2018.
- Y. M. Al-Hasan, G. A. Pinkas, and L. P. Thompson, “Prenatal hypoxia reduces mitochondrial protein levels and cytochrome c oxidase activity in offspring guinea pig hearts,” Reproductive Sciences, vol. 21, no. 7, pp. 883–891, 2014.
- P. Kaufmann, “Guinea pig Cavia porcellus,” Comparative Placentation, http://placentation.uscd.edu/guinea.htm.
- S. S. Jonker, J. J. Faber, D. F. Anderson, K. L. Thornburg, S. Louey, and G. D. Giraud, “Sequential growth of fetal sheep cardiac myocytes in response to simultaneous arterial and venous hypertension,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 292, no. 2, pp. R913–R919, 2007.
- I. Gostimskaya and A. Galkin, “Preparation of highly coupled rat heart mitochondria,” Journal of Visualized Experiments, no. 43, article e2202, 2010.
- Y. M. Al-Hasan, L. S. C. Evans, G. A. Pinkas, E. R. Dabkowski, W. C. Stanley, and L. P. Thompson, “Chronic hypoxia impairs cytochrome oxidase activity via oxidative stress in selected fetal guinea pig organs,” Reproductive Sciences, vol. 20, no. 3, pp. 299–307, 2013.
- K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001.
- P. Racay, Z. Tatarkova, A. Drgova, P. Kaplan, and D. Dobrota, “Ischemia-reperfusion induces inhibition of mitochondrial protein synthesis and cytochrome c oxidase activity in rat hippocampus,” Physiological Research, vol. 58, pp. 127–138, 2009.
- T. Yonetani and G. S. Ray, “Studies on cytochrome oxidase. VI. Kinetics of the aerobic oxidation of ferrocytochrome C by cytochrome oxidase,” The Journal of Biological Chemistry, vol. 240, pp. 3392–3398, 1965.
- W. Zhang, C. Chen, J. Wang, L. Liu, Y. He, and Q. Chen, “Mitophagy in cardiomyocytes and in platelets: a major mechanism of cardioprotection against ischemia/reperfusion injury,” Physiologie, vol. 33, no. 2, pp. 86–98, 2018.
- E. Fernández-Vizarra, V. Tiranti, and M. Zeviani, “Assembly of the oxidative phosphorylation system in humans: what we have learned by studying its defects,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1793, no. 1, pp. 200–211, 2009.
- S. Srinivasan and N. G. Avadhani, “Cytochrome c oxidase dysfunction in oxidative stress,” Free Radical Biology & Medicine, vol. 53, no. 6, pp. 1252–1263, 2012.
- J. St-Pierre, J. A. Buckingham, S. J. Roebuck, and M. D. Brand, “Topology of superoxide production from different sites in the mitochondrial electron transport chain,” The Journal of Biological Chemistry, vol. 277, no. 47, pp. 44784–44790, 2002.
- Q. Chen, E. J. Vazquez, S. Moghaddas, C. L. Hoppel, and E. J. Lesnefsky, “Production of reactive oxygen species by mitochondria: central role of complex III,” The Journal of Biological Chemistry, vol. 278, no. 38, pp. 36027–36031, 2003.
- H. Tsutsui, T. Ide, and S. Kinugawa, “Mitochondrial oxidative stress, DNA damage, and heart failure,” Antioxidants & Redox Signaling, vol. 8, no. 9-10, pp. 1737–1744, 2006.
- J. M. Berthiaume, J. G. Kurdys, D. M. Muntean, and M. G. Rosca, “Mitochondrial NAD+/NADH redox state and diabetic cardiomyopathy,” Antioxidants & Redox Signaling, vol. 30, no. 3, pp. 375–398, 2019.
- R. H. Lane, A. K. Chandorkar, A. S. Flozak, and R. A. Simmons, “Intrauterine growth retardation alters mitochondrial gene expression and function in fetal and juvenile rat skeletal muscle,” Pediatric Research, vol. 43, no. 5, pp. 563–570, 1998.
- G. D. Lopaschuk and J. S. Jaswal, “Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation,” Journal of Cardiovascular Pharmacology, vol. 56, no. 2, pp. 130–140, 2010.
- B. N. Finck and D. P. Kelly, “Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 10, pp. 1249–1257, 2002.
- J. Murray, S. W. Taylor, B. Zhang, S. S. Ghosh, and R. A. Capaldi, “Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry,” The Journal of Biological Chemistry, vol. 278, no. 39, pp. 37223–37230, 2003.
- A. Gabory, L. Attig, and C. Junien, “Sexual dimorphism in environmental epigenetic programming,” Molecular and Cellular Endocrinology, vol. 304, no. 1-2, pp. 8–18, 2009.
- A. Gabory, L. Attig, and C. Junien, “Developmental programming and epigenetics,” The American Journal of Clinical Nutrition, vol. 94, Supplement 6, pp. 1943S–1952S, 2011.
- B. Ostadal, I. Netuka, J. Maly, J. Besik, and I. Ostadalova, “Gender differences in cardiac ischemic injury and protection–experimental aspects,” Experimental Biology and Medicine, vol. 234, no. 9, pp. 1011–1019, 2009.
- A. R. M. Khalifa, E. A. Abdel-Rahman, A. M. Mahmoud et al., “Sex-specific differences in mitochondria biogenesis, morphology, respiratory function, and ROS homeostasis in young mouse heart and brain,” Physiological Reports, vol. 5, no. 6, article e13125, 2017.
- C. M. Klinge, “Estrogens regulate life and death in mitochondria,” Journal of Bioenergetics and Biomembranes, vol. 49, no. 4, pp. 307–324, 2017.
- V. L. Clifton, “Review: sex and the human placenta: mediating differential strategies of fetal growth and survival,” Placenta, vol. 31, Supplement, pp. S33–S39, 2010.
- H. Song, B. P. Telugu, and L. P. Thompson, “Sexual dimorphism of mitochondrial function in the hypoxic guinea pig placenta,” Biology of Reproduction, vol. 100, no. 1, pp. 208–216, 2019.
- G. Baños, O. N. Medina-Campos, P. D. Maldonado et al., “Antioxidant enzymes in hypertensive and hypertriglyceridemic rats: effect of gender,” Clinical and Experimental Hypertension, vol. 27, no. 1, pp. 45–57, 2005.
- J. Viña, C. Borrás, J. Gambini, J. Sastre, and F. V. Pallardó, “Why females live longer than males: control of longevity by sex hormones,” Science of Aging Knowledge Environment, vol. 2005, no. 23, p. pe17, 2005.
- K. M. Keller and S. E. Howlett, “Sex differences in the biology and pathology of the aging heart,” The Canadian Journal of Cardiology, vol. 32, no. 9, pp. 1065–1073, 2016.
- D. Pietraforte, E. Straface, P. Piscopo, R. Vona, and A. Confaloni, “Sex-related biomarkers in cardiovascular and neurodegenerative disorders,” Annali dell'Istituto Superiore di Sanità, vol. 52, no. 2, pp. 230–239, 2016.
- G. L. Semenza, “Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1,” Biochemical Journal, vol. 405, no. 1, pp. 1–9, 2007.
Copyright © 2019 Loren P. Thompson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.